Imunon Inc Sustainability Reports
Imunon, Inc. is a clinical-stage biotechnology company developing immunotherapies and next-generation DNA vaccines to treat cancer and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900PWLRCA840VVK89
1 reports from 2022 to 2022
Company Profile
Imunon, Inc. is a clinical-stage biotechnology company developing immunotherapies and next-generation DNA vaccines to treat cancer and infectious diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
